Opinion|Videos|December 15, 2025

Consequences of Relapse in Schizophrenia Care

Panelists discuss how relapse intensifies clinical and economic burdens, reinforcing the need for adherence and prevention-focused care.

Panelists discuss how relapse is one of the most significant challenges in schizophrenia management, often resulting in hospitalization, loss of function, and decreased medication adherence. Each relapse event tends to worsen disease prognosis and patient independence.

Panelists discuss how relapse also creates ripple effects for caregivers and the health care system, driving higher costs, increased emergency visits, and emotional burnout. The cyclical pattern of stabilization and relapse underscores the need for proactive adherence strategies.

Panelists discuss how maintaining treatment continuity through long-acting injectables, patient education, and multidisciplinary support can prevent relapse. The panel agrees that prevention

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo